Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Zweidler

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Leukemia Research|February 15, 2011
Targeting glycolysis in leukemia: a novel inhibitor 3-BrOP in combination with rapamycinLauren J Akers, Wendy Fang, Alejandro G Levy, et al.
Blood|January 13, 2011
Notch/HES1-mediated PARP1 activation: a cell type-specific mechanism for tumor suppressionSankaranarayanan Kannan, Wendy Fang, Guangchun Song, et al.
Cancer|March 13, 2010
A novel therapeutic combination for neuroblastoma: the vascular endothelial growth factor receptor/epidermal growth factor receptor/rearranged during transfection inhibitor vandetanib with 13-cis-retinoic acidPeter E Zage, Lizhi Zeng, Shana Palla, et al.
Blood|June 19, 2016
Inducible epithelial resistance protects mice against leukemia-associated pneumoniaMiguel M Leiva-Juárez, Hayden H Ware, Vikram V Kulkarni, et al.
Biochemistry|April 3, 1979
Physical properties of DNA and chromatin isolated from G1- and S-phase HeLa S-3 cells. Effects of histone H1 phosphorylation and stage-specific nonhistone chromosomal proteins on the molar ellipticity of native and reconstituted nucleoproteins during thermal denaturationT N Dolby, K Ajiro, T W Borun, et al.
Pediatric Blood & Cancer|November 22, 2011
Absolute lymphocyte counts refine minimal residual disease-based risk stratification in childhood acute lymphoblastic leukemiaKaren R Rabin, M Monica Gramatges, Michael J Borowitz, et al.
Plos One|May 3, 2013
Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemiaShao-Qing Kuang, Zhihong Fang, Patrick A Zweidler-McKay, et al.
Cancer|June 22, 2010
Signaling of ERBB receptor tyrosine kinases promotes neuroblastoma growth in vitro and in vivoKristen N Richards, Patrick A Zweidler-McKay, Nadine Van Roy, et al.
Cancer|October 21, 2010
The selective Trk inhibitor AZ623 inhibits brain-derived neurotrophic factor-mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecanPeter E Zage, Timothy C Graham, Lizhi Zeng, et al.
Cytotherapy|December 7, 2016
Non-fucosylated CB CD34<sup>+</sup> cells represent a good target for enforced fucosylation to improve engraftment following cord blood transplantationSimon N Robinson, Michael W Thomas, Paul J Simmons, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Leukemia Research|February 15, 2011
Targeting glycolysis in leukemia: a novel inhibitor 3-BrOP in combination with rapamycinLauren J Akers, Wendy Fang, Alejandro G Levy, et al.
Blood|January 13, 2011
Notch/HES1-mediated PARP1 activation: a cell type-specific mechanism for tumor suppressionSankaranarayanan Kannan, Wendy Fang, Guangchun Song, et al.
Cancer|March 13, 2010
A novel therapeutic combination for neuroblastoma: the vascular endothelial growth factor receptor/epidermal growth factor receptor/rearranged during transfection inhibitor vandetanib with 13-cis-retinoic acidPeter E Zage, Lizhi Zeng, Shana Palla, et al.
Blood|June 19, 2016
Inducible epithelial resistance protects mice against leukemia-associated pneumoniaMiguel M Leiva-Juárez, Hayden H Ware, Vikram V Kulkarni, et al.
Biochemistry|April 3, 1979
Physical properties of DNA and chromatin isolated from G1- and S-phase HeLa S-3 cells. Effects of histone H1 phosphorylation and stage-specific nonhistone chromosomal proteins on the molar ellipticity of native and reconstituted nucleoproteins during thermal denaturationT N Dolby, K Ajiro, T W Borun, et al.
Pediatric Blood & Cancer|November 22, 2011
Absolute lymphocyte counts refine minimal residual disease-based risk stratification in childhood acute lymphoblastic leukemiaKaren R Rabin, M Monica Gramatges, Michael J Borowitz, et al.
Plos One|May 3, 2013
Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemiaShao-Qing Kuang, Zhihong Fang, Patrick A Zweidler-McKay, et al.
Cancer|June 22, 2010
Signaling of ERBB receptor tyrosine kinases promotes neuroblastoma growth in vitro and in vivoKristen N Richards, Patrick A Zweidler-McKay, Nadine Van Roy, et al.
Cancer|October 21, 2010
The selective Trk inhibitor AZ623 inhibits brain-derived neurotrophic factor-mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecanPeter E Zage, Timothy C Graham, Lizhi Zeng, et al.
Cytotherapy|December 7, 2016
Non-fucosylated CB CD34<sup>+</sup> cells represent a good target for enforced fucosylation to improve engraftment following cord blood transplantationSimon N Robinson, Michael W Thomas, Paul J Simmons, et al.
Pageof 8